Belite Bio, Inc. (BLTE)
158.36
-5.64
(-3.44%)
USD |
NASDAQ |
Jan 09, 16:00
160.00
+1.64
(+1.04%)
After-Hours: 05:09
Belite Bio Research and Development Expense (Quarterly): 10.31M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Ocugen, Inc. | 10.20M |
| Ionis Pharmaceuticals, Inc. | 217.13M |
| Ligand Pharmaceuticals, Inc. | 21.02M |
| IDEAYA Biosciences, Inc. | 82.99M |
| Terns Pharmaceuticals, Inc. | 19.92M |